Evidence map›Paper›PMID 31633708›Full record

ReviewChemical communications (Cambridge, England)2019

Beyond protein binding: recent advances in screening DNA-encoded libraries.

Thomas Kodadek, Nicholas G Paciaroni, Madeline Balzarini, Paige Dickson

Open access · greenAbstract readReview
In one paragraph

Review in Chemical communications (Cambridge, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Small-molecule discovery through DNA-encoded libraries.Nature reviews. Drug discovery · 2023
    Review
  6. Building Block-Based Binding Predictions for DNA-Encoded Libraries.Journal of chemical information and modeling · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. PROTACs to address the challenges facing small molecule inhibitors.European journal of medicinal chemistry · 2021
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Thomas KodadekDepartment of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA. kodadek@scripps.edu.ORCID http://orcid.org/0000-0003-1930-4795
Nicholas G PaciaroniDepartment of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA. kodadek@scripps.edu.ORCID http://orcid.org/0000-0001-5799-1544
Madeline BalzariniDepartment of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA. kodadek@scripps.edu.ORCID http://orcid.org/0000-0001-9756-6091
Paige DicksonDepartment of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA. kodadek@scripps.edu.ORCID http://orcid.org/0000-0002-9196-2031
Scripps Research Institute · US

Funding

Phenotypic screening using DNA-encoded librariesR01GM133041 · NIGMS · UNIVERSITY OF FLORIDA · PI KODADEK, THOMAS J. · 2018 to 2021
$3.2M
NIGMS NIH HHS R01 GM133041
6 · The paper itself

Abstract

DNA-encoded library (DEL) screening has emerged as an important method for early stage drug and probe molecule discovery. The vast majority of screens using DELs have been relatively simple binding assays. The library is incubated with a target molecule, which is almost always a protein, and the DNAs that remain associated with the target after thorough washing are amplified and deep sequenced to reveal the chemical structures of the ligands they encode. Recently however, a number of different screening formats have been introduced that demand more than simple binding. These include a format that demands hits exhibit high selectivity for target vs. off-targets, a protocol to screen for enzyme inhibitors and another to identify organocatalysts in a DEL. These and other novel assay formats are reviewed in this article. We also consider some of the most significant remaining challenges in DEL assay development.

Indexed as

Gene LibraryLigandsPeptide LibraryDrug DiscoveryEnzyme InhibitorsHumansMembrane ProteinsPhosphotransferasesProtein BindingEnzyme InhibitorsLigandsMembrane ProteinsPeptide LibraryPhosphotransferases

Identifiers

PMID31633708
PMCPMC6939232
OpenAlexW2981109304

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.